The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis (Q39530952)

12 September 2017

The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis (English)

1 reference

12 September 2017

5

Peter Bartenstein

1 reference

12 September 2017

Wolfgang Peter Mueller

1

1 reference

12 September 2017

Henriette Ingrid Melzer

2

1 reference

12 September 2017

Irene Schmid

3

1 reference

12 September 2017

Eva Coppenrath

4

1 reference

12 September 2017

Thomas Pfluger

6

1 reference

12 September 2017

25 October 2012

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

12 September 2017

1 reference

12 September 2017

40

1 reference

12 September 2017

3

1 reference

12 September 2017

356-363

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-012-2278-6

12 September 2017

0 references

cites work

Risk factors for diabetes insipidus in langerhans cell histiocytosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

A randomized trial of treatment for multisystem Langerhans' cell histiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Extraosseous langerhans cell histiocytosis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

The role of radiology in the diagnosis and follow-up of Langerhans cell histiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Central nervous system disease in Langerhans cell histiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Role of 18FDG-positron emission tomography scanning in the management of histiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Langerhans cell histiocytosis with central nervous system involvement: follow-up by FDG-PET during treatment with cladribine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Whole-body MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Paediatric manifestations of Langerhans cell histiocytosis: a review of the clinical and radiological findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Fast STIR whole-body MR imaging in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

Pulmonary magnetic resonance imaging for airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2278-6

PET-CT in pediatric Langerhans cell histiocytosis

21 January 2018

1 reference

12 December 2020

FDG-PET: procedure guidelines for tumour imaging

1 reference

12 December 2020

Langerhans cell histiocytosis

1 reference

12 December 2020

Defining the role of magnetic resonance imaging in unifocal bone lesions of langerhans cell histiocytosis

1 reference

12 December 2020

The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis

1 reference

12 December 2020

Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions

1 reference

12 December 2020

Central nervous system disease in Langerhans cell histiocytosis

1 reference

12 December 2020

10.1007/S00259-012-2278-6

Identifiers

DOI

1 reference

12 September 2017

1 reference